Poultry Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (ELISA and PCR), By Disease Type (Avian Salmonellosis, Avian Influenza, Newcastle Disease, and Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 534.10 Million
CAGR (2026-2031)	9.01%
Fastest Growing Segment	ELISA
Largest Market	North America
Market Size (2031)	USD 896.23 Million

Market Overview

The Global Poultry Diagnostics Market will grow from USD 534.10 Million in 2025 to USD 896.23 Million by 2031 at a 9.01% CAGR. Poultry diagnostics encompass the specialized reagents, test kits, and instruments utilized to detect pathogens and monitor the health of avian livestock. The market is primarily propelled by the escalating global demand for animal-derived protein which necessitates rigorous disease surveillance to ensure food security and supply chain stability. Furthermore, the increasing prevalence of transboundary zoonotic diseases compels producers to adopt stringent testing protocols to comply with international trade regulations and animal welfare standards. Major producing regions contribute significantly to this volume; according to the National Chicken Council, in 2024, the United States produced over 9.4 billion broiler chickens, demonstrating the immense scale of operations that require continuous health monitoring to prevent outbreaks.

Despite this positive trajectory, the market faces a significant challenge regarding the high operational costs associated with advanced diagnostic technologies. The financial burden of implementing sophisticated molecular testing infrastructure often outweighs the immediate economic benefits for small-scale producers in developing regions. Consequently, this disparity in accessibility creates a vulnerability in global disease management and may impede the widespread expansion of the diagnostics market in these price-sensitive areas.

Key Market Drivers

Growing global consumption of poultry meat and eggs is fundamentally reshaping the diagnostics landscape, as producers intensify operations to meet the surging demand for affordable protein. This rapid expansion necessitates rigorous health monitoring protocols to prevent supply chain disruptions and ensure flock productivity. As production density increases to satisfy market needs, the reliance on diagnostic testing becomes critical for maintaining herd health and maximizing yield. According to the OECD-FAO Agricultural Outlook, published in July 2024, global poultry meat consumption is projected to reach 160 million metric tons by 2033, underscoring the long-term pressure on producers to optimize output. To support this trajectory, the industry is already operating at massive scales; according to the USDA, in April 2024, global chicken meat production was forecast to reach 103.3 million tons for the year. This immense volume of livestock requires continuous surveillance, directly fueling the uptake of diagnostic solutions.

Concurrently, the increasing prevalence of zoonotic and infectious avian diseases acts as a severe catalyst for the adoption of advanced detection methods. Pathogens not only threaten animal welfare but also impose devastating financial losses on the industry, compelling stakeholders to invest in rapid and accurate testing infrastructure. Effective diagnostics are the first line of defense in mitigating outbreaks that can lead to mass culling and trade embargoes. The economic burden of these ailments is substantial; according to the National Library of Medicine, in 2024, the parasitic disease Coccidiosis alone is estimated to cost the poultry industry between $2.4 billion and $3 billion annually. Such financial risks drive the prioritization of early detection technologies, ensuring that outbreaks are contained before they escalate into region-wide crises.

Download Free Sample Report

Key Market Challenges

The Global Poultry Diagnostics Market encounters a substantial barrier to growth driven by the high operational and capital costs required for advanced molecular testing and automated platforms. These diagnostic methods necessitate expensive instrumentation, specialized reagents, and skilled personnel to interpret results, creating a financial structure that is often unsustainable for small and medium-scale producers. In emerging economies where profit margins are narrow, the expense of implementing such rigorous testing protocols often outweighs the perceived immediate value, forcing farmers to rely on less accurate, traditional observation methods rather than investing in precise diagnostic tools.

This economic constraint directly limits the Total Addressable Market (TAM) for diagnostic manufacturers, effectively stalling expansion in regions that otherwise hold high volume potential. By restricting adoption to wealthy, industrialized nations, the market fails to capitalize on the critical need for disease management in price-sensitive areas. The scale of this missed opportunity is highlighted by the global prevalence of transboundary diseases; according to the World Organisation for Animal Health, in 2024, highly pathogenic avian influenza affected 82 countries and territories worldwide. Despite this widespread geographical reach of pathogens, the prohibitive cost of testing infrastructure prevents the diagnostics market from achieving commensurate growth in these affected territories.

Key Market Trends

The Integration of Artificial Intelligence for Predictive Disease Modeling is revolutionizing the sector by shifting the focus from reactive diagnosis to proactive health management. Advanced algorithms are now capable of analyzing continuous data streams from barn environments—such as water consumption patterns and vocalization acoustics—to identify subtle physiological anomalies that precede visible clinical signs. This capability allows producers to intervene days earlier than traditional methods permit, significantly mitigating outbreak severity and reducing antibiotic reliance. Illustrating this technological leap, according to WATTPoultry, October 2025, in the article 'New take on water data could boost poultry disease detection', the CEO of Optifarm reported that their AI-driven analysis of drinking routines can now detect innate immune system responses in flocks with over 91% certainty, providing a critical early warning system for producers without requiring new hardware.

Simultaneously, the Implementation of DIVA (Differentiating Infected from Vaccinated Animals) Strategies is gaining urgent momentum as the industry adapts to the endemic nature of Highly Pathogenic Avian Influenza (HPAI). Because traditional mass-culling policies are becoming economically unsustainable, there is a strategic pivot toward vaccination, which necessitates companion diagnostics that can distinguish between vaccinated birds and those infected with the wild-type virus to maintain international trade eligibility. Underscoring this regulatory and financial shift, according to dvm360, April 2025, in the report 'USDA announces $100M funding opportunity for avian influenza solutions', the USDA allocated up to $100 million specifically to support the development of vaccines and therapeutics that are compatible with DIVA testing protocols to safeguard the nation's poultry supply.

Segmental Insights

The Enzyme-Linked Immunosorbent Assay (ELISA) segment represents the fastest-growing category within the global poultry diagnostics market due to its high efficiency in mass surveillance. Poultry producers increasingly adopt this method because it offers a cost-effective solution for screening large flocks while delivering consistent and reliable results. Organizations such as the World Organisation for Animal Health frequently validate ELISA protocols for monitoring major infectious diseases, reinforcing industry confidence in this technology. Consequently, the ability to facilitate early disease detection and maintain flock health continues to drive the widespread adoption of ELISA testing across the agricultural sector.

Regional Insights

North America maintains a dominant position in the Global Poultry Diagnostics Market, primarily driven by stringent animal health regulations and a well-established livestock sector. The United States Department of Agriculture (USDA) enforces rigorous surveillance programs to control the spread of infectious diseases like Avian Influenza, necessitating frequent diagnostic testing. Additionally, the region experiences high domestic consumption of poultry products, which compels producers to adhere to strict safety protocols to maintain flock health. These factors, combined with a strong focus on food safety standards, ensure North America remains the primary revenue contributor to the global market.

Recent Developments

• In June 2025, a newly developed diagnostic test kit for the detection of the highly pathogenic H5 strain of avian influenza was commercially launched and licensed for distribution in Southeast Asia. The Steadfast H5-HPAI test kit, which originated from a collaboration between the Diagnostics Development Hub and international research institutes, was licensed to BioAcumen Global for regional supply. Designed for use in centralized laboratories, the kit demonstrated high sensitivity and specificity, enabling the detection of the virus within three hours. This product launch provided national surveillance systems with a vital tool for the early identification of bird flu outbreaks in poultry.
• In August 2024, BioChek entered into a strategic partnership with Bio-X Diagnostics to consolidate their respective strengths in the animal health diagnostics sector. This collaboration brought together BioChek’s specialized expertise in poultry and swine diagnostics with Bio-X’s focus on swine and ruminant testing. The agreement included plans for BioChek to acquire a minority share in Bio-X, facilitating the integration of their research and development departments and expanding their geographical reach. The companies aimed to leverage their combined product lines and technical know-how to deliver comprehensive diagnostic solutions to the global veterinary market, directly benefiting the poultry industry.
• In July 2024, Alveo Technologies Inc. announced the development and upcoming shipment of a rapid molecular diagnostic test for avian influenza, specifically targeting the H5N1 variants. The company introduced the Flockscreen LAMP Avian Influenza Molecular Test, which was designed to analyze cloacal and oropharyngeal samples from poultry using a ruggedized, handheld platform. This solution was positioned to provide accurate results at the point of need, effectively supplementing limited laboratory resources during critical outbreaks. The company confirmed that shipments of the new test to markets in Europe and the Middle East were scheduled to commence in the third quarter of that year.
• In April 2024, BioStone Animal Health expanded its specialized portfolio with the commercial introduction of a new real-time PCR detection kit designed for the specific identification of Avian Influenza Virus subtypes. The company launched the Avian Influenza Virus H5/H7 Dual Real-Time PCR Detection Kit to assist veterinary laboratories in the rapid and accurate diagnosis of these high-risk pathogen strains. This strategic product release addressed the critical industry need for precise surveillance tools to efficiently manage viral outbreaks. The kit was made available as part of a broader effort to enhance disease monitoring capabilities within the global poultry diagnostics market.

Key Market Players

• Zoetis Services LLC
• QIAGEN N.V.
• BioChek BV
• Bioneer Corporation
• Thermo Fisher Scientific Inc.
• MEGACOR Diagnostik GmbH
• IDEXX Laboratories, Inc.
• Randox Laboratories Ltd.
• INDICAL Bioscience GmbH
• Heska Corporation

By Test Type	By Disease Type	By Region
ELISA and PCR	Avian Salmonellosis Avian Influenza Newcastle Disease and Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Poultry Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Poultry Diagnostics Market, By Test Type:

• ELISA and PCR

• Poultry Diagnostics Market, By Disease Type:

• Avian Salmonellosis
• Avian Influenza
• Newcastle Disease
• and Others

• Poultry Diagnostics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE